BLCO logo

Bausch Lomb (BLCO)

Profile

Full Name

Bausch + Lomb Corporation

Ticker Symbol

BLCO

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

Canada

IPO

May 6, 2022

Indexes

Not included

Website

http://www.bausch.com

Employees

13500

Key Details

Price

$12.06(+1.77%)

Market cap

$4.26B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.79B(+15.56% YoY)

Annual EPS

-$0.90(-21.62% YoY)

PE ratio

-

Next earnings date

Apr 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$12.06
BLCO price is $12.06

30-Day Relative Volume

1.11
BLCO 30-day relative volume is 1.11

Price Performance

Price Most recent change

+1.77%
BLCO price was up +1.77% on Apr 17, 2025

Price YTD change

-33.22%
BLCO price is down -33.22% since January 1st

Price 1-year change

-15.72%
BLCO price is down -15.72% year-on-year

Price 3-year change

-
BLCO price 3-year change is unknown

Price Range

Price All-time high

$21.95
BLCO price is currently -45.06% below its historical high of $21.95

Price 3-year low

$10.46
BLCO price is currently +15.30% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.26B
BLCO market capitalization is $4.26 billion

Market cap 3-year change

-
BLCO market capitalization 3-year change is unknown

Market cap All-time high

$7.51B
BLCO market capitalization is currently -43.26% below its historical high of $7.51 billion

Market cap sector rank

88.48%
BLCO market capitalization is higher than 88.48% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.51%
BLCO shares outstanding is up +0.51% year-on-year

Shares Outstanding 3-Year Change

-
BLCO shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.11
BLCO beta is 1.11

200-day SMA

$17.19
BLCO price is currently -29.84% below its 200-day simple moving average

50-day SMA

$14.86
BLCO price is currently -18.84% below its 50-day simple moving average

RSI

38.44
BLCO 14-day relative strength index is 38.44

Volume

1.11
BLCO 30-day relative volume is 1.11

ATR

$0.74
BLCO average true range is $0.74

10-day Historical Volatility

112.77%
BLCO 10-day historical volatility is 112.77%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.79B
BLCO annual revenue is $4.79 billion

Revenue Analysts estimate

$4.99B
BLCO annual revenue is currently -4.05% lower than the consensus analysts' forecast

Revenue 1-year change

+15.56%
BLCO annual revenue is up +15.56% year-on-year

Revenue Sector rank

91.7%
BLCO annual revenue is higher than 91.7% of companies in Healthcare sector

EPS

EPS

-$0.90
BLCO annual earnings per share is -$0.90

EPS Analysts estimate

$0.64
BLCO annual earnings per share is currently -240.06% lower than the consensus analysts' forecast

EPS 1-year change

-21.62%
BLCO annual earnings per share is down -21.62% year-on-year

EPS Sector rank

58.66%
BLCO annual earnings per share is higher than 58.66% of companies in Healthcare sector

Profit

Gross profit

$2.92B
BLCO annual gross profit is $2.92 billion

Gross margin

60.93%
BLCO annual gross profit margin is 60.93%

Operating profit

$188.00M
BLCO annual operating income is $188.00 million

Operating margin

3.92%
BLCO annual operating profit margin is 3.92%

Net income

-$317.00M
BLCO annual net profit is -$317.00 million

Net margin

-6.62%
BLCO annual net profit margin is -6.62%

Expenses

Total expenses

$4.60B
BLCO annual total expenses is $4.60 billion

Operating expenses

$2.73B
BLCO annual total operating expenses is $2.73 billion

Cost of goods sold

$1.87B
BLCO annual cost of goods sold is $1.87 billion

Selling, general & administrative expenses

$2.08B
BLCO annual SGA is $2.08 billion

Depreciation and amortization

$436.00M
BLCO annual depreciation & amortization is $436.00 million

Interest expense

$399.00M
BLCO annual interest expense is $399.00 million

Income tax

$71.00M
BLCO annual income tax is $71.00 million

EBIT & EBITDA

EBIT

$165.00M
BLCO annual earnings before interest & taxes is $165.00 million

EBITDA

$601.00M
BLCO annual EBITDA is $601.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$13.47B
BLCO annual total assets is $13.47 billion

Non current assets

$10.68B
BLCO annual long term assets is $10.68 billion

Current assets

$2.79B
BLCO annual total current assets is $2.79 billion

Cash and cash equivalents

$305.00M
BLCO annual cash & cash equivalents is $305.00 million

Accounts receivable

$1.03B
BLCO annual accounts receivable is $1.03 billion

Inventory

$1.04B
BLCO annual inventory is $1.04 billion

Liabilities

Total liabilities

$6.92B
BLCO annual total liabilities is $6.92 billion

Long term liabilities

$5.19B
BLCO annual total long term liabilities is $5.19 billion

Current liabilities

$1.74B
BLCO annual total current liabilities is $1.74 billion

Accounts payable

$389.00M
BLCO annual accounts payable is $389.00 million

Debt

Total debt

$4.78B
BLCO annual total debt is $4.78 billion

Total debt 1-year change

+4.87%
BLCO annual total debt is up +4.87% year-on-year

Long term debt

$4.74B
BLCO annual long term debt is $4.74 billion

Short term debt

$40.00M
BLCO annual short term debt is $40.00 million

Equity & Capital

Shareholders equity

$6.47B
BLCO annual stockholders equity is $6.47 billion

Book value

$6.47B
BLCO annual book value is $6.47 billion

Retained earnings

-$571.00M
BLCO annual retained earnings is -$571.00 million

Working capital

$1.05B
BLCO annual working capital is $1.05 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$232.00M
BLCO annual cash flow from operations is $232.00 million

Cash from operations 1-year change

+1464.71%
BLCO annual cash flow from operations is up +1464.71% year-on-year

Cash from investing

-$412.00M
BLCO annual cash flow from investing activities is -$412.00 million

Cash from investing 1-year change

+80.46%
BLCO annual cash flow from investing activities is up +80.46% year-on-year

Cash from financing

$178.00M
BLCO annual cash flow from financing activities is $178.00 million

Cash from financing 1-year change

-91.43%
BLCO annual cash flow from financing activities is down -91.43% year-on-year

CAPEX

CAPEX

$291.00M
BLCO annual capital expenditures is $291.00 million

CAPEX 1-year change

+60.77%
BLCO annual capital expenditures is up +60.77% year-on-year

Free Cash Flow

Free cash flow

-$59.00M
BLCO annual free cash flow is -$59.00 million

Free cash flow 1-year change

+70.2%
BLCO annual free cash flow is up +70.2% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

60.93%
BLCO annual gross profit margin is 60.93%

Operating margin

3.92%
BLCO annual operating profit margin is 3.92%

Net margin

-6.62%
BLCO annual net profit margin is -6.62%

ROA & ROE

ROA

-2.36%
BLCO annual return on assets is -2.36%

ROE

-4.71%
BLCO annual return on equity is -4.71%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BLCO price to earnings ratio value is unknown

PE ratio Sector rank

-
BLCO price to earnings ratio is unknown

PB Ratio

PB ratio

0.66
BLCO price to book ratio is 0.66

PB ratio Sector rank

35.04%
BLCO price to book ratio is higher than 35.04% of companies in Healthcare sector

PS Ratio

PS ratio

0.89
BLCO price to sales ratio is 0.89

PS ratio Sector rank

25.8%
BLCO price to sales ratio is higher than 25.8% of companies in Healthcare sector

Enterprise value

Enterprise value

$8.74B
BLCO enterprise value is $8.74 billion

Enterprise value Sector rank

91.49%
BLCO enterprise value is higher than 91.49% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

14.54
BLCO EV/EBITDA is 14.54

EV/EBITDA Sector rank

87.73%
BLCO EV/EBITDA is higher than 87.73% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.60
BLCO annual current ratio is 1.60

Quick ratio

1.01
BLCO annual quick ratio is 1.01

Leverage

Debt to equity

0.74
BLCO annual debt to equity ratio is 0.74

Interest coverage ratio

0.41
BLCO annual interest coverage ratio is 0.41

Risk & Stability

Piotroski F-Score

4
BLCO piotroski f-score is 4

Altman Z-Score

0.80
BLCO altman z-score is 0.80

Analyst ratings

Recent major analysts updates

Apr 4, 25 RBC Capital
Outperform
Apr 3, 25 Stifel
Hold
Mar 28, 25 Wells Fargo
Equal-Weight
Feb 21, 25 HC Wainwright & Co.
Buy
Feb 20, 25 RBC Capital
Outperform
Feb 20, 25 Needham
Hold
Feb 20, 25 B of A Securities
Underperform
Feb 18, 25 HC Wainwright & Co.
Buy
Jan 29, 25 Stifel
Hold
Jan 29, 25 RBC Capital
Outperform

Institutional Ownership

Similar stocks

ELAN logo
Elanco Animal Health Incorporated (ELAN)
ALKS logo
Alkermes (ALKS)
INSP logo
Inspire Medical Systems (INSP)
IONS logo
Ionis Pharmaceuticals (IONS)
PBH logo
Prestige Consumer Healthcare (PBH)
PCVX logo
Vaxcyte (PCVX)
ITGR logo
Integer Holdings (ITGR)
RYTM logo
Rhythm Pharmaceuticals (RYTM)
CYTK logo
Cytokinetics Incorporated (CYTK)
  • What is the ticker symbol for Bausch Lomb?
  • Does Bausch Lomb pay dividends?
  • What sector is Bausch Lomb in?
  • What industry is Bausch Lomb in?
  • What country is Bausch Lomb based in?
  • When did Bausch Lomb go public?
  • Is Bausch Lomb in the S&P 500?
  • Is Bausch Lomb in the NASDAQ 100?
  • Is Bausch Lomb in the Dow Jones?
  • When was Bausch Lomb's last earnings report?
  • When does Bausch Lomb report earnings?
  • Should I buy Bausch Lomb stock now?

What is the ticker symbol for Bausch Lomb?

The ticker symbol for Bausch Lomb is NYSE:BLCO

Does Bausch Lomb pay dividends?

No, Bausch Lomb does not pay dividends

What sector is Bausch Lomb in?

Bausch Lomb is in the Healthcare sector

What industry is Bausch Lomb in?

Bausch Lomb is in the Medical Instruments & Supplies industry

What country is Bausch Lomb based in?

Bausch Lomb is headquartered in Canada

When did Bausch Lomb go public?

Bausch Lomb's initial public offering (IPO) was on May 6, 2022

Is Bausch Lomb in the S&P 500?

No, Bausch Lomb is not included in the S&P 500 index

Is Bausch Lomb in the NASDAQ 100?

No, Bausch Lomb is not included in the NASDAQ 100 index

Is Bausch Lomb in the Dow Jones?

No, Bausch Lomb is not included in the Dow Jones index

When was Bausch Lomb's last earnings report?

Bausch Lomb's most recent earnings report was on Feb 19, 2025

When does Bausch Lomb report earnings?

The next expected earnings date for Bausch Lomb is Apr 30, 2025

Should I buy Bausch Lomb stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page